About Neurapy
Neurapy is a company based in Chennai (India) founded in 2018 by Madan Kumar Govindarajan and Pushparaja S. It operates as a B2B and B2C. Neurapy offers products and services including VisuoPrime Home Edition, VisuoPrime Professional Edition, and OptoPrime Professional Edition. Neurapy operates in a competitive market with competitors including Radius XR, 2EyesVision, Myopia, Olympic Ophthalmics and Optimo Medical, among others.
- Headquarter Chennai, India
- Founders Madan Kumar Govindarajan, Pushparaja S
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Neurapy Private Limited
- Date of Incorporation 20 Sep, 2018
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$22.91 K (USD)150.07as on Mar 31, 2020
-
Net Profit
-$7.07 K (USD)-412.45as on Mar 31, 2020
-
EBITDA
$885.75 (USD)-84.7as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurapy
Neurapy offers a comprehensive portfolio of products and services, including VisuoPrime Home Edition, VisuoPrime Professional Edition, and OptoPrime Professional Edition.
Software for treating eye problems at home with doctor guidance.
Software to diagnose and treat eye issues in clinical settings.
VR-based tools for advanced treatment of vision problems.
Funding Insights of Neurapy
Detailed funding history for Neurapy
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurapy
Investment portfolio details for Neurapy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurapy
Detailed financials for Neurapy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurapy Comparisons
Peer comparison for Neurapy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurapy
Neurapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radius XR, 2EyesVision, Myopia, Olympic Ophthalmics and Optimo Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of wearable patient engagement and diagnostic system
|
|
| Locked | Locked | Locked |
Portable technologies for multifocal eye corrections before surgeries are developed.
|
|
| Locked | Locked | Locked |
Myopia prevention app monitors family screen habits and distances.
|
|
| Locked | Locked | Locked |
Provider and developer of tear production device for treatments of dry eye disease
|
|
| Locked | Locked | Locked |
Delivers digital software for cornea detection in healthcare settings.
|
Detailed competitors of Neurapy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurapy
Complete news archive for Neurapy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurapy
Neurapy was founded in 2018.
Neurapy is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Madan Kumar Govindarajan is the current CEO of Neurapy. They have also founded this company.
Annual revenue of Neurapy is $22.91K as on Mar 31, 2020.
Neurapy develops specialized software and tools for vision therapy, focusing on conditions like Amblyopia and Strabismus. They provide home-based editions for patient use under doctor guidance with cloud monitoring, and professional editions for clinics to diagnose and treat eye problems. The company enables customized prescriptions and immersive experiences, collaborating with healthcare professionals to improve vision care through innovative technology.
Neurapy's top competitors include 2EyesVision, Myopia and Radius XR.
Neurapy offers VisuoPrime Home Edition, VisuoPrime Professional Edition, and OptoPrime Professional Edition.